COMPASS Pathways Plc Sponsored ADR CMPS 深 沪
等待开盘 05-11 09:30:00 美东时间
9.915
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 9.915
- 总市值 42.15万
- 52周最高 10.21
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 2.25
- 委 比 0.00%
- 总股本 4.25万
- 历史最高 61.69
- 量 比 0
- 振 幅 0.00%
- 历史最低 1.10
- 每 手 1
- 风险率 1.41%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Newsom Torches Trump's Psychedelic Mental Health Order In Just Two Words: 'For Himself?'
Gavin Newsom's press office mocked Trump's initiative after Karoline Leavitt shared a White House fact sheet on psychedelic drug treatments, replying: "For himself?"
04-21 14:57
Market-Moving News for April 20th
MRVL: 7% | Google Teams Up With Marvell Technology To Build New AI Chips, Invests Heavily In TPU Strategy Amid Nvidia Dominance: Report CMND: 110% | Clearmind Medicine Says CMND-100, Proprietary
04-20 19:30
Why TopBuild Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
TopBuild Corp (NYSE: BLD) rises in pre-market trading after QXO (NYSE: QXO) agrees to acquire for $17 billion. Shares jump 20.2% to $493.01.
04-20 16:37
Compass Pathways Announces Exercise Of 35,059,448 Warrants For Proceeds Of ~$200M
Compass Pathways plc (NASDAQ:CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the exercise of 35,059,448 warrants, which were issued on January 13,
02-26 19:40
Compass Pathways Commences $150M Offering
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the launch of a proposed public offering of $150.0 million of American
02-18 05:30
木头姐大举买入Block股票 减持Shopify
凯西·伍德旗下ARK基金于8月11日大举买入Block（XYZ）股票，扫货价值约1920万美元的股份，显示出对这家金融科技公司“逢低买入”的操作策略。根据ARK每日交易披露，旗舰基金ARKK购入152，980股Block股票，ARKW增持69，526股，ARKF买入39，957股。 该基金集团同时扩大了在生物科技和数据类股票的头寸，增持1，415股CRISPR Therapeutics（CRSP）、59，880股Personalis（PSNL）以及23，970股Compass Pathways（CMPS）。另一方面，ARK减持了Shopify（SHOP）股票，在该股财报公布后上涨之际卖...
2025-08-13 03:31
Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference
Compass Therapeutics will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 5, 2025, from 11:05 to 11:35 AM ET. More details and a webcast link are available.
2025-05-28 12:00
Psilocybin Breakthrough: Study Reveals Potential Application For Body Dysmorphic Disorder
New study suggests psilocybin may help treat body dysmorphic disorder by rewiring brain connectivity and reducing obsessive thought patterns.
2024-09-27 05:13
'DEA Calls For Massive Increases In Psilocybin, Ibogaine And THC Manufacturing This Year To Meet Research Demands' - Marijuana Moment
https://www.marijuanamoment.net/dea-calls-for-massive-increases-in-psilocybin-ibogaine-and-thc-manufacturing-this-year-to-meet-research-demands/The Drug Enforcement Administration (DEA) is proposing a dramatic increase
2024-09-24 01:41
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
The U.S. Food and Drug Administration (FDA) has issued a complete response lett...
2024-09-13 08:28
